Technical Scrutiny on Consumer Staples Stocks -- Research on Diageo, Clorox, Campbell Soup, and Rock Creek Pharma Editor Note: For more information about this release, please scroll to bottom.
LONDON, June 13, 2014 /PRNewswire/ --
On Thursday, June 12, 2014, the NASDAQ Composite ended at 4,297.63, down 0.79%, the Dow Jones Industrial Average edged 0.65% lower, to finish the day at 16,734.19, and the S&P 500 closed at 1,930.11, down 0.71%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Consumer Staples Sector Index ended the day at 457.51, down 0.85%, while the index has advanced 4.60% in the previous three months. Investor-Edge has initiated coverage on the following equities: Diageo PLC (NYSE: DEO), The Clorox Co. (NYSE: CLX), Campbell Soup Co. (NYSE: CPB) and Rock Creek Pharmaceuticals Inc. (NASDAQ: RCPI). Free technical research on DEO, CLX, CPB and RCPI can be downloaded upon signing up at:
On Thursday, Diageo PLC's stock fluctuated between $128.78 and $129.84 before ending the session 0.86% higher at $129.24. Diageo PLC's stock reported a trading volume of 0.31 million shares, below its three months average volume of 0.49 million shares. Diageo PLC's shares have advanced 2.72% in the last one month and 6.74% in the previous three months. However, the company's stock has lost 2.40% since the start of this year. The stock is trading above its 50-day and 200-day moving averages of $125.80 and $126.16, respectively. Moreover, shares of the company have a Relative Strength Index (RSI) of 54.44. Sign up today to read free research on DEO at:
The Clorox Co.'s stock edged 0.91% lower, to close the day at $90.40. The stock recorded a trading volume of 1.05 million shares, below its three months average volume of 1.18 million shares. The stock oscillated between $89.96 and $91.21 during the session. Over the last one month and over the past three months, The Clorox Co.'s shares have gained 2.49% and 4.16%, respectively. However, the stock has declined 2.54% since the beginning of this year. The stock is trading above its 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $89.16 is greater than its 200-day moving average of $88.27. Additionally, the stock traded at a PE ratio of 20.78 and has an RSI of 60.77. Sign up today to read free research on CLX at:
On Thursday, shares in Campbell Soup Co. recorded a trading volume of 0.57 million shares, lower than its three months average volume of 1.12 million shares. The stock ended the day at $45.26, which was 0.37% below its previous day's closing of $45.43, and registered an intraday range of $45.12 and $45.54. Shares of the company traded at a PE ratio of 19.50. Although Campbell Soup Co.'s shares have lost 0.51% in the past one month, it has advanced 2.38% in the last three months and 4.57% on YTD basis. The company's stock is trading above its 50-day and 200-day moving averages of $45.01 and $42.85, respectively. Furthermore, shares of the company have an RSI of 52.03. Sign up today to read free research on CPB at:
Rock Creek Pharmaceuticals Inc.'s stock finished the Thursday's session 0.26% lower at $0.77. A total of 0.48 million shares were traded, which was below its three months average volume of 1.00 million shares. The stock moved between $0.72 and $0.78 during the session. Over the last three trading sessions and the previous one month, Rock Creek Pharmaceuticals Inc.'s shares have surged 6.17% and 18.76%, respectively. However, from the beginning of 2014, the company's stock has declined 33.97%. The company's shares are trading above their 50-day moving average of $0.67, while the 50-day moving average is below Rock Creek Pharmaceuticals Inc.'s 200-day moving average of $1.19. Rock Creek Pharmaceuticals Inc.'s stock has an RSI of 63.65. Sign up today to read free research on RCPI at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.